1960
DOI: 10.1001/archderm.1960.01580050067008
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

The Treatment of Mycosis Fungoides with a New Agent, Cyclophosphamide (Cytoxan)

Search citation statements

Order By: Relevance

Paper Sections

Select...
13
0
0
0

Citation Types

0
6
0
0

Year Published

1961
1961
2015
2015

Publication Types

Select...
11
2

Relationship

0
13

Authors

Journals

citations

Cited by 13 publications

(6 citation statements)
references

References 2 publications

0
6
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…Since 1960, cyclophosphamide has been used in the treatment of this disease. Abele and Dobson (1960) treated 4 cases with good results in all. Adam (1963) treated a case in the premycotic stage and found cyclophosphamide effective.…”
mentioning
confidence: 95%
How this paper cites the one you are viewing
“…Since 1960, cyclophosphamide has been used in the treatment of this disease. Abele and Dobson (1960) treated 4 cases with good results in all. Adam (1963) treated a case in the premycotic stage and found cyclophosphamide effective.…”
mentioning
confidence: 95%
How this paper cites the one you are viewing
“…Although multiple studies have shown that single-agent cyclophosphamide has activity against MF/SS, the benefit is often low. [61][62][63][64][65][66] Abele and Dobson 61 reported 4 cases, mostly with early-stage disease, who showed a response. Van Scott and colleagues 66 subsequently reported 11 more cases, with 5 patients responding to single-agent cyclophosphamide at 50 to 300 mg/d for up to 117 days.…”
Section: Ifosfamide
mentioning
confidence: 99%
How this paper cites the one you are viewing
“…With the exception of the lower (400-700 mg weekly) maintenance regimen of Abele and Dobson, 228 in which the main side effects seen in 4 patients treated for 2 to 12 months were alopecia, nausea, and vomiting with no leukopenia or thrombocytopenia, leukopenia 229 has been the doselimiting factor for continuous dosing. The potential for hemorrhagic cystitis with oral dosing and, in young patients, germ cell damage, remain as concerns.…”
Section: Alkylating Agents
mentioning
confidence: 99%